RIVA, ELISABETTA
 Distribuzione geografica
Continente #
AS - Asia 5.807
NA - Nord America 1.011
EU - Europa 580
SA - Sud America 238
AF - Africa 38
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.700
Nazione #
SG - Singapore 4.579
US - Stati Uniti d'America 956
CN - Cina 586
HK - Hong Kong 455
GB - Regno Unito 180
IT - Italia 179
BR - Brasile 172
VN - Vietnam 89
DE - Germania 70
CA - Canada 39
IN - India 38
NL - Olanda 29
AR - Argentina 23
AU - Australia 23
FI - Finlandia 21
ZA - Sudafrica 20
EC - Ecuador 18
UA - Ucraina 18
CZ - Repubblica Ceca 15
PL - Polonia 14
TR - Turchia 14
ID - Indonesia 11
JP - Giappone 9
MX - Messico 9
ES - Italia 8
FR - Francia 8
PY - Paraguay 7
RU - Federazione Russa 7
BD - Bangladesh 5
EE - Estonia 5
MA - Marocco 5
VE - Venezuela 5
BE - Belgio 4
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
PE - Perù 3
PK - Pakistan 3
AM - Armenia 2
BF - Burkina Faso 2
IL - Israele 2
KE - Kenya 2
LT - Lituania 2
PA - Panama 2
UY - Uruguay 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NR - Nauru 1
PT - Portogallo 1
RO - Romania 1
SL - Sierra Leone 1
TH - Thailandia 1
TJ - Tagikistan 1
TO - Tonga 1
TW - Taiwan 1
UG - Uganda 1
VG - Isole Vergini Britanniche 1
Totale 7.700
Città #
Hong Kong 454
Singapore 400
Hefei 283
Ashburn 226
Boardman 194
London 156
Beijing 129
Shanghai 98
Dallas 80
Council Bluffs 66
Rome 55
Ho Chi Minh City 43
San Francisco 36
Munich 30
Los Angeles 28
Pune 24
Toronto 24
São Paulo 22
Seattle 20
Santa Clara 19
Washington 18
Amsterdam 17
Milan 16
New York 16
West Jordan 15
Warsaw 14
Brno 13
Hanoi 13
Brooklyn 12
Helsinki 11
Melbourne 10
Sydney 10
Turku 10
Boston 9
Chicago 8
Montreal 8
Tokyo 8
Chennai 7
Johannesburg 7
Quito 7
Brescia 6
Guayaquil 6
Mexico City 6
Belo Horizonte 5
Hangzhou 5
Hải Dương 5
Manchester 5
Atlanta 4
Bologna 4
Da Nang 4
Ferrara 4
Haiphong 4
Nuremberg 4
Redmond 4
Secaucus 4
Settimo Torinese 4
Sona 4
Stockholm 4
The Dalles 4
Verona 4
Ananindeua 3
Asunción 3
Basel 3
Berlin 3
Campinas 3
Canberra 3
Cape Town 3
Centurion 3
Charlotte 3
Cotia 3
Curitiba 3
Denver 3
Guangzhou 3
Haikou 3
Lima 3
Miami 3
Pittsburgh 3
Rio de Janeiro 3
Surbiton 3
Altamura 2
Barcelona 2
Bari 2
Belém 2
Biên Hòa 2
Brasília 2
Brussels 2
Buenos Aires 2
Buffalo 2
Bắc Giang 2
Casavatore 2
Falconara Marittima 2
Guarulhos 2
Guiyang 2
Hanover 2
Hortolândia 2
Huế 2
Imbé 2
Lanús 2
Montevideo 2
Nairobi 2
Totale 2.805
Nome #
Real-time polymerase chain reaction with melting analysis of positive blood culture specimens in bloodstream infections: diagnostic value and turnaround time 210
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 206
A case of hepatitis B virus infection in Eritrean Diciotti migrant: phylogenetic analysis and 'mirror effect' 202
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease control 202
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients 196
SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department 194
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 194
Comparison of the Allplex TM Respiratory Panel Assays and the Automated Fast Track Diagnostics Respiratory Pathogens 21 Assay for the Diagnosis of Pediatric Respiratory Viral Infections 193
Alterazioni del sistema interferon in patologie umane: basi biologiche per un intervento terapeutico [The alteration of IFN system in human diseases: Biological basis for a therapy] 188
). Diagnosi Delle Infezioni Virali 180
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 179
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 172
Aspetti virologici della patogenesi dell’infezione da HIV 169
Capitolo 26. Spirochete 162
Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19 152
Cine¬tica di replicazione dell'HIV su C8166: aspetti biologici ed applicativi. 151
Antibodies to IFN in chronic patients treated with rIFN alpha. 151
Influenza B virus infection complicated by life-threatening pericarditis: A unique case-report and literature review 141
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women 134
An acute febrile outbreak in a refugee community of an Italian asylum seeker center: lessons learned. Ciccozzi M., Riva E. share co-first authorship 99
MALDI-TOF MS Identification and Clustering Applied to Enterobacter Species in Nosocomial Setting 97
Acquired immunodeficiency virus (HIV-1). Biological aspects and virological diagnosis [Il virus dell'immunodeficienza acquisita (HIV-1). Aspetti biologici e diagnosi virologica] 96
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight 94
Genomic Epidemiology Unveil the Omicron Transmission Dynamics in Rome, Italy 91
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 91
Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics 89
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision 87
Cronobacter sakazakii DNA detection in cerebrospinal fluid of a patient with amyotrophic lateral sclerosis mimic syndrome 86
Classificazione E Struttura Dei Virus Animali 85
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 84
Diffuse maculopapular rash: A family cluster during the last Chikungunya virus epidemic in Italy 82
Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C. 82
Classificazione E Struttura Dei Virus 82
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? 82
Azione antivirale dell'interferon e di altri inibitori naturali. Giornale Italiano di Chemioterapia 80
Cellular factors leading to AZT resistance of HIV. 78
Anti-interferon (IFN) antibodies in patients with relapsing remitting multipla sclerosis treated with recombinant IFN1a or IFN1b 78
Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy 76
Alteration of thymidine kinase activity in cells treated with an antiviral agent. 76
“Classificazione e struttura dei virus” 46
Human Immunodeficiency Virus (HIV) DNA load and the level of immunosuppression in Treatment-Naïve HIV-1 Infected Patients 44
IMMUNOCOMPLESSI CIRCOLANTI (IC) IN PAZIENTI HCV POSITIVI 44
Plasma HIV viremia and viral load in lymph nodes 39
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 37
THE NUMBER OF HIV DNA-INFECTED MONONUCLEAR CELLS IS REDUCED UNDER HAART PLUS RECOMBINANT IL-2 36
Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 36
Multidrug-Resistant Klebsiella pneumoniae Strains in a Hospital: Phylogenetic Analysis to Investigate Local Epidemiology 35
Spirochete (Cap. 26) 35
In Vitro Selection Of Human Immunodeficiency Virus Type 1 Resistant To 3'-Azido-3'-Deoxythymidine. 35
Drug-induced cell mediated mechanism leading to resistance of HIV to AZT 34
Diagnosi Delle Infezioni Virali 33
Quantitative hiv-1 proviral DNA detection: a multicentre analysis 33
IS HUMAN IMMUNODEFICIENCY VIRUS RNA LOAD COMPOSED OF NEUTRALIZED IMMUNE COMPLEXES? 33
Influence of Hepatitis C virus (HCV) genotype, HCV RNA load and ALT level on reduction of HCV RNA after a single administration of interferon alpha 32
Neutralizing and Nonneutralizing antibodies to IFN in hepatitis patients treated with different IFN alpha preparations. 32
MIGLIORAMENTO DELLA PERFORMANCE E GESTIONE DELLA ROUTINE MOLECOLARE NEL LABORATORIO DI VIROLOGIA DEL POLICLINICO UNIVERSITARIO CAMPUS BIO-MEDICO (UCBM) ATTRAVERSO L’UTILIZZO DI UN SISTEMA COMPLETAMENTE AUTOMATICO. 32
Patogenesi Dell'infezione Da HIV: Determinazione Quantitativa Del DNA Provirale Nel Monitoraggio Clinico Terapeutico 31
Sinergismo fra AZT e ddI nell'infezione da HIV-1: aspetti biologici ed applica¬tivi. 31
Fattori di non progressione nell'infezione da HIV. 31
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients 31
LA COINFEZIONE HIV/HPV 31
Diagnosi delle Infezioni Virali 31
High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic 30
Spirochete 30
Evaluation of cellular associated HIV-1 DNA levels in HIV-1 infected patients receiving a long term of highly active antiretroviral therapy 30
Studio sulla farmacoresistenza cellulare all'AZT 30
vitro selection of HIV-1 resistance to ddI is no as efficient as for the other antiretroviral drugs and yields virus which shows reduced cytophatic activity. 30
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 29
Il virus dell'immunodeficienza acquisita: aspetti biologici e diagnosi virologica. 29
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy 29
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 29
Zidovudine induces the expression of cellular resistance affecting its antiviral activity. 29
STUDIO SULLE MUTAZIONI DI HIV-1 ASSOCIATE A FARMACORESISTENZA NEL PLASMA E NELLE CELLULE MONONUCLEATE DI SANGUE PERIFERICO 29
Was Aldo Castellani the inventor of combined and polyvalent vaccines? 28
The new Chikungunya virus outbreak in Italy possibly originated from a single introduction from Asia. 28
Susceptibility to measles in migrant population: implication for policy makers. Ceccarelli G., Vita S., Riva E. share co-first authorship 28
LYSOSOMAL ACID LIPASE ACTIVITY IS REDUCED IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED WITH SURROGATE INDICES OF PORTAL HYPERTENSION 28
IMPACT OF THE IL28B RS12979860 CT POLYMORPHISM ON THE CYTOMEGALOVIRUS REACTIVATION IN AUTOLOGOUS STEM CELL TRANSPLANT PATIENTS 28
The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mrnas for interferon-induced proteins. Intervirology 28
Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy 27
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. 27
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay 26
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 26
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor 26
Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support 25
IMPROVEMENT OF INTERLEUKIN 2 PRODUCTION, CLONOGENIC CAPABILITY AND RESTORATION OF STROMAL CELL FUNCTION IN HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 PATIENTS AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY 25
Drug combination Of AZT And Ddi: Synergism Of Action And Prevention of Appearance of AZT-Resistance 25
The biologiccal basis foer clinical use of interferon in infectious diseases 25
MARCATORI MOLECOLARI DELL’INFEZIONE DA HPV IN DONNE HIV-NEGATIVE E HIV-POSITIVE 25
Role of the IL28B Rs12979860 C/T Polymorphism on the Incidence of Clinically-Active Cytomegalovirus Infection in Autologous Stem Cell Transplant Patients 25
Transmission of zidovudine-resistant HIV during a bloody fight. 24
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy 24
IMPAIRED 2’-3’-DIDEOXY-3’-THIACYTIDINE ACCUMULATION IN T LYMPHOBLASTOID CELLS AS A MECHANISM OF ACQUIRED RESISTANCE INDEPENDENT OF MULTIDRUG-RESISTANT PROTEIN 4 WITH A POSSIBLE ROLE FOR ATP-BINDING CASSETTE C11 24
La reazione di polimerizzazione a catena. 24
Storia nataurale dell'infezione da HIv nel tossicodipendente 24
The SARS-CoV-2 Epidemic: How the Italian Public Is Being Informed 24
MARCATORI MOLECOLARI DELL’INFEZIONE DA HPV 24
Quando il virus è 'camaleontico. In “LE INFEZIONI VIRALI “ 24
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 24
Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy 23
Totale 6.906
Categoria #
all - tutte 58.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 0 0 0 1 1 1 1 12 6 2 177
2022/202381 3 1 1 2 9 1 4 6 3 8 39 4
2023/2024530 13 62 19 44 59 230 2 22 2 23 7 47
2024/20255.522 84 30 185 49 51 97 82 13 377 392 1.920 2.242
2025/20261.389 431 235 250 445 28 0 0 0 0 0 0 0
Totale 7.723